Jinshi data November 7 news, Fuxiang Pharmaceutical announced on the evening of November 7 that, in order to accelerate the expansion of the microbial protein business market, the company plans to invest in setting up Fuxiang Microbial Protein Application Consumer Product Development and Sales subsidiaries in Shanghai and Singapore, with registered capital of no more than 10 million RMB and 3 million Singapore dollars respectively.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Fusheng Pharmaceutical: Plans to establish subsidiaries in Shanghai and Singapore to expand the microbial protein business
Jinshi data November 7 news, Fuxiang Pharmaceutical announced on the evening of November 7 that, in order to accelerate the expansion of the microbial protein business market, the company plans to invest in setting up Fuxiang Microbial Protein Application Consumer Product Development and Sales subsidiaries in Shanghai and Singapore, with registered capital of no more than 10 million RMB and 3 million Singapore dollars respectively.